Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-24

Clinical Trial Update: Faecal Microbiota Transplantation for Liver Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on faecal microbiota transplantation for liver cirrhosis, currently recruiting in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Faecal Microbiota Transplantation

Snippet

Sponsor: University of Aarhus | Conditions: Liver Cirrhosis | Phase 2, Phase 3 | Status: RECRUITING